SCHEMBL8279786

SCHEMBL8279786

C=CNCc1cc(-c2ccc(OC)cc2)no1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.63
CYP1A2 P05177 1/20 0.63
ALDH1A1 P00352 4/20 0.59
LMNA P02545 2/20 0.59
HTT P42858 2/20 0.59
POLB P06746 1/20 0.59
CYP3A4 P08684 1/20 0.57
CYP2C9 P11712 1/20 0.57
MAPT P10636 4/20 0.55
NPC1 O15118 3/20 0.55
RAB9A P51151 3/20 0.55
L3MBTL1 Q9Y468 2/20 0.55
TDP1 Q9NUW8 1/20 0.55
HPGD P15428 2/20 0.55
KMT2A Q03164 2/20 0.55
NAAA Q02083 1/20 0.45
PAX8 Q06710 1/20 0.45
CA12 O43570 1/20 0.44
CA9 Q16790 1/20 0.44
CYP11B1 P15538 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14452004 0.83 SMN1; SMN2 (0.69) SMN1; SMN2CYP1A2ALDH1A1LMNAHTT
SCHEMBL14438267 0.80 SMN1; SMN2 (0.64) SMN1; SMN2CYP1A2ALDH1A1LMNAHTT
SCHEMBL14591949 0.78 SMN1; SMN2 (0.65) SMN1; SMN2CYP1A2ALDH1A1LMNAHTT
SCHEMBL1566524 0.77 SMN1; SMN2 (0.63) SMN1; SMN2CYP1A2ALDH1A1LMNAHTT
SCHEMBL1221306 0.77 MAPT (0.66) SMN1; SMN2CYP1A2ALDH1A1LMNAHTT
SCHEMBL2898452 0.77 NOTUM (0.64) SMN1; SMN2CYP1A2ALDH1A1LMNAHTT
SCHEMBL1566577 0.77 SMN1; SMN2 (0.64) SMN1; SMN2CYP1A2ALDH1A1LMNAHTT
SCHEMBL28432486 0.75 MAPT (0.89) SMN1; SMN2CYP1A2ALDH1A1LMNAHTT
SCHEMBL6402396 0.75 SMN1; SMN2 (0.77) SMN1; SMN2CYP1A2ALDH1A1LMNAHTT
SCHEMBL15013473 0.75 SMN1; SMN2 (0.56) SMN1; SMN2CYP1A2ALDH1A1LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005095343-A1 DPP-IV INHIBITORS SANTHERA PHARMACEUTICALS (SCHWEIZ) GMBH (CH) 2005-10-13 WO disclosed